Abstract:Peroxiredoxin-I is a protein encoded by the Peroxiredoxin I gene, which highly expressed in many tumor tissues, such as lung cancer, breast cancer, rectal cancer, stomach cancer. Peroxiredoxin-I has a proliferative effect and plays a role in cancer development, recurrence or progression. The mAb 109 antibody can specific binding to Peroxiredoxin-I protein. We recently reported the synthesis Tc-99m-labeled mAb109 for Single-photon emission computed tomography (SPECT) imaging. Those studies have showed that Tc-99m-mAb 109 still preserved its biological functions and specifically binding to the target tumors. The aim of this research was to develop new radionuclide labeled mAb109 antibody for prolonged tumor targeted molecular imaging. In this paper, the precursor compound 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10-tetraacetic acid-mAb 109 (DOTA-mAb109) was synthesized for potential radioactive imaging agents. Then, a radioisotope indium-111 (t(1/2)= 67.3 h) was labeling to DOTA-mAb109 for further radio-biological evaluation. The DOTA is chelated to the In-111(3+) center through four nitrogens and four carboxylate oxygens, resulting in an eight-coordinate complex. The labeling efficiency of In-111-DOTA-mAb109 was tested by Radio-TLC/HPLC. The radiolabeling yield was over 96%, the radio chemical purity was over 99% by PD-10 column purification. The in vitro stability tests were presented in 5% Human serum albumin (HSA) for 72 h at 25 degrees C Less than 5% In-111 dissociation was detected by Radio-HPLC. In-111-DOTA-mAb109 shows excellent radiochemical property. Nano-SPECT imaging of pancreatic carcinoma-1 tumor-bearing nude mice revealed that tumor uptake of In-111-DOTA-mAb109 got a gradual accumulation from 24 h, 48 h to 72 h after post-injection of 18.5 MBq radiolabeled antibody. The cardiac area was clearly seen up to 48 h post injection, reflecting a long blood circulation time for In-111-DOTA-mAb109. Uptake in the tumor was clearly visualized by emission computed tomography. These results suggest that the In-111-DOTA-mAb109 molecular probe is a promising tracer for tumor diagnosis.

Synthesis and evaluation of 111 In-labeled d -glucose as a potential SPECT imaging agent

Synthesis and Evaluation of (68)Ga-Labeled DOTA-2-deoxy-D-glucosamine As a Potential Radiotracer in Μpet Imaging.

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

Synthesis and Evaluation of New Nuclides Ga-68 Labeled D-Glucose for Potential PET Imaging Agent

The Preparation and Execution of Exploratory Human Studies on Novel 99Mtc-Labeled Glucosamine Derivatives Containing Different Phenyl Isonitriles As Promising Tumor Imaging Agents.

Radio-Labeling and Micro-Pet Study of Cu-64 Labeled D-Glucose for Tumor Imaging

Evaluation and Comparison of 99mtc‐labeled D‐glucosamine Derivatives with Different 99mtc Cores As Potential Tumor Imaging Agents

Noninvasive Scintigraphic Detection of Tumor with 99Mtc-Dtpa-deoxyglucose: an Experimental Study.

Novel 99Mtc-Labeled Glucose Derivative for Single Photon Emission Computed Tomography: A Promising Tumor Imaging Agent

Synthesis and biological evaluation of a &lt;sup&gt;99m&lt;/sup&gt;Tc-labeled glucose derivative for tumor imaging

Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA

Synthesis and Biodistribution of A New 99Mtc-Oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

Synthesis and Radiolabeling of (111)In-Core-cross Linked Polymeric Micelle-Octreotide for Near-Infrared Fluoroscopy and Single Photon Emission Computed Tomography Imaging.

Preparation and Bioevaluation of a Novel 99Mtc-Labeled Glucose Derivative Containing Cyclohexane As a Promising Tumor Imaging Agent

Design, Synthesis And Evaluation Of Dual-Modality Glyco-Nanoparticles For Tumor Imaging

Synthesis and Biological Evaluation of a Novel (99m)tc Nitrido Radiopharmaceutical with Deoxyglucose Dithiocarbamate, Showing Tumor Uptake.

Design and Synthesis of 111In-Ccpm-rgd Nanoparticles for Dual-modality Molecular Imaging

Synthesis and Evaluation of a 99m Tc-labeled Deoxyglucose Derivative As a Potential Agent to Target Tumor

Synthesis and Biological Evaluation of Novel 99Mtc(co)3-Labeled Thymidine Analogs As Potential Probes for Tumor Proliferation Imaging

99Tcmn-Dgdtc,a New Glucose Metabolic Agent,the Pharmacokinetics and Imaging Results

The Synthesis and Evaluations of the 68Ga-Lissamine Rhodamine B (LRB) As a New Radiotracer for Imaging Tumors by Positron Emission Tomography